Differential iNKT and T Cells Activation in Non-Alcoholic Fatty Liver Disease and Drug-Induced Liver Injury
Metadatos
Afficher la notice complèteEditorial
MDPI
Materia
Non-alcoholic fatty liver disease (NAFLD) Drug-induced liver injury (DILI) Immunophenotype Immune response Liver fibrosis
Date
2021-12-28Referencia bibliográfica
Caballano-Infantes, E... [et al.]. Differential iNKT and T Cells Activation in Non-Alcoholic Fatty Liver Disease and Drug-Induced Liver Injury. Biomedicines 2022, 10, 55. [https://doi.org/10.3390/biomedicines10010055]
Patrocinador
Instituto de Salud Carlos III PI18/01804 PI19/00883 PI21/01248; Junta de Andalucia UMA18-FEDERJA-194 PI18-RT-3364 PI-0285-2016; FEDER funds ("A way to make Europe") ("Andalucia se mueve con Europa")Résumé
Background: Non-alcoholic fatty liver disease (NAFLD) and idiosyncratic drug-induced liver injury (DILI) could share molecular mechanisms involving the immune system. We aimed to identify activation immunological biomarkers in invariant natural killer T (iNKT) and CD4/CD8+ T cells in NAFLD and DILI. Methods: We analyzed the activation profile (CD69, CD25, and HLA-DR) and natural killer group 2 member D (NKG2D) on iNKT cells, and CD4/CD8 T cells in peripheral blood mononuclear cells from NAFLD, with or without significant liver fibrosis, and DILI patients. Results: There was an increase in iNKT cells in NAFLD patients compared to DILI or control subjects. Regarding the cellular activation profile, NAFLD with significant liver fibrosis (F >= 2) displayed higher levels of CD69+iNKT cells compared to NAFLD with none or mild liver fibrosis (F <= 1) and control patients. CD69+iNKT positively correlated with insulin resistance, aspartate aminotransferase (AST) level, liver fibrosis-4 index (FIB4) and AST to Platelet Ratio Index (APRI). DILI patients showed an increase in CD69+ and HLA-DR+ in both CD4+ and CD8+ T cells, detecting the most relevant difference in the case of CD69+CD8+ T cells. Conclusions: CD69+iNKT may be a biomarker to assess liver fibrosis progression in NAFLD. CD69+CD8+ T cells were identified as a potential distinctive biomarker for distinguishing DILI from NAFLD.
Colecciones
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Atribución 3.0 España
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.